Biotricity Change To Netincome vs Other Non Cash Items Analysis

BTCY Stock

USD 1.06 0.01 0.95%

Biotricity financial indicator trend analysis is way more than just evaluating Biotricity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biotricity is a good investment. Please check the relationship between Biotricity Change To Netincome and its Other Non Cash Items accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Change To Netincome vs Other Non Cash Items

Change To Netincome vs Other Non Cash Items Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biotricity Change To Netincome account and Other Non Cash Items. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Biotricity's Change To Netincome and Other Non Cash Items is 0.51. Overlapping area represents the amount of variation of Change To Netincome that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Biotricity, assuming nothing else is changed. The correlation between historical values of Biotricity's Change To Netincome and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Netincome of Biotricity are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Change To Netincome i.e., Biotricity's Change To Netincome and Other Non Cash Items go up and down completely randomly.

Correlation Coefficient

0.51

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Change To Netincome

Other Non Cash Items

Most indicators from Biotricity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 11.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2024.

Biotricity fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Short Term Investments	Inventory
Total Assets		0.78	0.2	0.6	-0.49	0.61	0.53	-0.81	0.57	0.82	0.82	0.89	0.58	0.28	0.8	0.79	0.76	0.97	0.57	0.7	-0.3	0.76	0.83	0.75	0.68	0.62
Short Long Term Debt Total	0.78		0.24	0.88	-0.9	0.72	0.94	-0.93	0.95	0.3	0.3	0.9	0.6	0.34	0.99	0.92	0.99	0.62	0.88	0.74	-0.26	0.99	0.87	0.78	0.97	0.97
Other Current Liab	0.2	0.24		0.63	-0.4	0.38	0.23	-0.4	0.31	0.06	0.06	0.44	0.53	0.1	0.17	0.38	0.35	0.2	0.56	0.46	-0.92	0.14	0.25	0.2	0.35	0.2
Total Current Liabilities	0.6	0.88	0.63		-0.93	0.77	0.88	-0.9	0.92	0.1	0.1	0.87	0.7	0.31	0.82	0.88	0.93	0.44	0.99	0.77	-0.62	0.83	0.74	0.69	0.94	0.87
Total Stockholder Equity	-0.49	-0.9	-0.4	-0.93		-0.67	-0.97	0.85	-0.97	0.07	0.07	-0.75	-0.58	-0.3	-0.86	-0.82	-0.93	-0.31	-0.94	-0.69	0.38	-0.89	-0.75	-0.68	-0.95	-0.95
Current Deferred Revenue	0.61	0.72	0.38	0.77	-0.67		0.65	-0.88	0.76	0.26	0.26	0.77	0.9	0.33	0.68	0.91	0.75	0.5	0.81	0.89	-0.49	0.69	0.62	0.7	0.75	0.67
Net Debt	0.53	0.94	0.23	0.88	-0.97	0.65		-0.83	0.98	-0.04	-0.04	0.75	0.49	0.3	0.92	0.82	0.95	0.33	0.9	0.63	-0.21	0.94	0.75	0.66	0.96	0.99
Retained Earnings	-0.81	-0.93	-0.4	-0.9	0.85	-0.88	-0.83		-0.89	-0.4	-0.4	-0.94	-0.82	-0.37	-0.9	-0.97	-0.94	-0.7	-0.9	-0.91	0.48	-0.9	-0.87	-0.86	-0.92	-0.86
Accounts Payable	0.57	0.95	0.31	0.92	-0.97	0.76	0.98	-0.89		0.02	0.02	0.79	0.63	0.32	0.92	0.89	0.96	0.38	0.94	0.74	-0.32	0.94	0.75	0.72	0.96	0.98
Cash	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02		1.0	0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.15	0.07
Cash And Short Term Investments	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02	1.0		0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.15	0.07
Net Receivables	0.89	0.9	0.44	0.87	-0.75	0.77	0.75	-0.94	0.79	0.53	0.53		0.7	0.33	0.86	0.9	0.91	0.8	0.85	0.8	-0.51	0.86	0.86	0.8	0.9	0.8
Common Stock Total Equity	0.58	0.6	0.53	0.7	-0.58	0.9	0.49	-0.82	0.63	0.33	0.33	0.7		0.49	0.58	0.82	0.64	0.55	0.71	0.97	-0.63	0.56	0.64	0.72	0.61	0.52
Common Stock Shares Outstanding	0.28	0.34	0.1	0.31	-0.3	0.33	0.3	-0.37	0.32	0.12	0.12	0.33	0.49		0.33	0.35	0.34	0.24	0.32	0.49	-0.09	0.33	0.35	0.33	0.34	0.32
Non Current Liabilities Total	0.8	0.99	0.17	0.82	-0.86	0.68	0.92	-0.9	0.92	0.35	0.35	0.86	0.58	0.33		0.9	0.97	0.65	0.82	0.73	-0.2	0.99	0.87	0.76	0.92	0.95
Other Stockholder Equity	0.79	0.92	0.38	0.88	-0.82	0.91	0.82	-0.97	0.89	0.38	0.38	0.9	0.82	0.35	0.9		0.93	0.66	0.89	0.9	-0.44	0.89	0.81	0.79	0.89	0.86
Total Liab	0.76	0.99	0.35	0.93	-0.93	0.75	0.95	-0.94	0.96	0.26	0.26	0.91	0.64	0.34	0.97	0.93		0.6	0.93	0.77	-0.37	0.97	0.86	0.78	0.98	0.97
Total Current Assets	0.97	0.62	0.2	0.44	-0.31	0.5	0.33	-0.7	0.38	0.92	0.92	0.8	0.55	0.24	0.65	0.66	0.6		0.41	0.66	-0.3	0.59	0.78	0.7	0.5	0.43
Short Term Debt	0.57	0.88	0.56	0.99	-0.94	0.81	0.9	-0.9	0.94	0.05	0.05	0.85	0.71	0.32	0.82	0.89	0.93	0.41		0.77	-0.57	0.85	0.72	0.72	0.95	0.89
Common Stock	0.7	0.74	0.46	0.77	-0.69	0.89	0.63	-0.91	0.74	0.39	0.39	0.8	0.97	0.49	0.73	0.9	0.77	0.66	0.77		-0.55	0.71	0.8	0.83	0.73	0.66
Net Tangible Assets	-0.3	-0.26	-0.92	-0.62	0.38	-0.49	-0.21	0.48	-0.32	-0.18	-0.18	-0.51	-0.63	-0.09	-0.2	-0.44	-0.37	-0.3	-0.57	-0.55		-0.18	-0.27	-0.36	-0.36	-0.19
Non Current Assets Total	0.76	0.99	0.14	0.83	-0.89	0.69	0.94	-0.9	0.94	0.27	0.27	0.86	0.56	0.33	0.99	0.89	0.97	0.59	0.85	0.71	-0.18		0.86	0.79	0.95	0.97
Non Currrent Assets Other	0.83	0.87	0.25	0.74	-0.75	0.62	0.75	-0.87	0.75	0.48	0.48	0.86	0.64	0.35	0.87	0.81	0.86	0.78	0.72	0.8	-0.27	0.86		0.86	0.82	0.8
Other Assets	0.75	0.78	0.2	0.69	-0.68	0.7	0.66	-0.86	0.72	0.43	0.43	0.8	0.72	0.33	0.76	0.79	0.78	0.7	0.72	0.83	-0.36	0.79	0.86		0.75	0.7
Short Term Investments	0.68	0.97	0.35	0.94	-0.95	0.75	0.96	-0.92	0.96	0.15	0.15	0.9	0.61	0.34	0.92	0.89	0.98	0.5	0.95	0.73	-0.36	0.95	0.82	0.75		0.97
Inventory	0.62	0.97	0.2	0.87	-0.95	0.67	0.99	-0.86	0.98	0.07	0.07	0.8	0.52	0.32	0.95	0.86	0.97	0.43	0.89	0.66	-0.19	0.97	0.8	0.7	0.97

Click cells to compare fundamentals

Biotricity Account Relationship Matchups

Biotricity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Short Long Term Debt Total	2.3M	4.7M	15.4M	19.5M	22.5M	23.6M
Other Current Liab	427.6K	3.6M	520.7K	1.0M	1.2M	977.3K
Total Current Liabilities	3.8M	10.5M	4.9M	11.2M	12.8M	13.5M
Total Stockholder Equity	(3.0M)	(6.8M)	(2.1M)	(19.8M)	(17.9M)	(17.0M)
Net Debt	1.4M	2.5M	3.3M	19.0M	21.8M	22.9M
Retained Earnings	(46.4M)	(62.8M)	(93.0M)	(112.6M)	(101.3M)	(96.2M)
Accounts Payable	1.1M	1.0M	1.2M	3.4M	4.0M	4.1M
Cash	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Cash And Short Term Investments	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Net Receivables	623.3K	1.8M	2.4M	1.8M	2.1M	2.2M
Common Stock Total Equity	31.9K	35.4K	36.4K	39.0K	44.9K	27.8K
Common Stock Shares Outstanding	6.0M	6.3M	7.6M	8.7M	10.0M	7.3M
Liabilities And Stockholders Equity	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Non Current Liabilities Total	1.2M	780.9K	14.0M	15.2M	17.5M	18.3M
Other Stockholder Equity	44.2M	56.6M	91.6M	92.8M	106.7M	112.1M
Total Liab	5.0M	11.3M	18.8M	26.4M	30.3M	31.8M
Total Current Assets	1.7M	4.3M	15.3M	4.7M	5.4M	3.2M
Accumulated Other Comprehensive Income	(857.3K)	(634.2K)	(768.7K)	(152.8K)	(137.5K)	(144.4K)
Short Term Debt	2.3M	4.3M	1.8M	5.1M	5.9M	6.2M
Common Stock	36.4K	39.0K	51.3K	52.5K	60.4K	33.8K
Net Tangible Assets	(1.8M)	(3.0M)	(6.8M)	(2.1M)	(1.9M)	(2.0M)
Non Current Assets Total	345.6K	116.5K	1.4M	1.8M	2.1M	2.2M
Short Term Investments	137.1K	326.7K	302.3K	588.6K	676.9K	710.7K
Inventory	85.7K	272.5K	842.9K	2.3M	2.7M	2.8M
Other Current Assets	137.1K	326.7K	406.3K	588.6K	676.9K	710.7K
Short Long Term Debt	2.1M	4.3M	1.5M	4.8M	5.5M	5.8M
Net Invested Capital	(932.1K)	(2.2M)	11.9M	(2.0M)	(2.3M)	(2.2M)
Net Working Capital	(2.1M)	(6.2M)	10.5M	(6.4M)	(5.8M)	(5.5M)
Capital Stock	36.4K	39.0K	51.3K	52.5K	60.4K	47.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:

How To Invest In Biotricity

Details

Is Biotricity Stock a good investment?

Details

What is Biotricity's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.

	Money Managers Screen money managers from public funds and ETFs managed around the world
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Global Correlations Find global opportunities by holding instruments from different markets
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.75)

Revenue Per Share

1.319

Quarterly Revenue Growth

0.209

Return On Assets

(0.95)

Return On Equity

(41.01)

The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biotricity Change To Netincome vs Other Non Cash Items Analysis

Change To Netincome vs Other Non Cash Items

Change To Netincome vs Other Non Cash Items Correlation Analysis

Correlation Coefficient

Change To Netincome

Other Non Cash Items

Biotricity fundamental ratios Correlations

Biotricity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biotricity fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Biotricity Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Short Long Term Debt Total
Short Term Debt	+ 0.99	Total Current Liabilities
Inventory	+ 0.99	Net Debt

Other Stockholder Equity	- 0.97	Retained Earnings
Accounts Payable	- 0.97	Total Stockholder Equity
Net Debt	- 0.97	Total Stockholder Equity
Inventory	- 0.95	Total Stockholder Equity
Short Term Investments	- 0.95	Total Stockholder Equity
Total Liab	- 0.94	Retained Earnings